Alternative Delivery Strategies for Hiv Prevention & Treatment

Total Page:16

File Type:pdf, Size:1020Kb

Alternative Delivery Strategies for Hiv Prevention & Treatment ALTERNATIVE DELIVERY STRATEGIES FOR HIV PREVENTION & TREATMENT by Ethel D. Weld, MD A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland April 2019 Abstract The three parts of this thesis are as follows: 1) A comparative pre-phase I study exploring the impact of volume of microbicide gel vehicle on distribution through the distal colon, user experience, and acceptability (Section II); 2) An analysis of the colorectal distribution of lymphocytes and cell-free HIV surrogate in autologous seminal plasma following simulated anal intercourse (Section III); and 3) A survey study exploring the interest of U.S. youth living with HIV in long-acting injectable antiretrovirals (Section IV). Section II: Methods: Eight HIV negative men with a history of recent RAI were enrolled into a two- period, sequence randomized, dosing study comparing 3.5 mL and 10 mL of radiolabeled (1 mCi 99mTc-DTPA) universal placebo hydroxyethyl cellulose (HEC) gel. Each participant received two doses in the research unit, one of each volume, separated by a washout period of at least 2 weeks. Each research unit dose was followed by a self-administered take-home dose. Safety and gastrointestinal distribution were assessed after the research unit doses; safety, perceptibility, and acceptability were assessed after take-home doses. Results: There were no adverse effects of Grade 2 or higher and all resolved spontaneously. Both volumes were well tolerated and received high acceptability scores. The 3.5 mL and 10 mL gel volumes distributed similarly (p>0.2) within the rectosigmoid. Both volumes covered the typical gastrointestinal distribution of ejaculate following simulated intercourse based on other studies. Conclusion: Either of these gel volumes could reasonably be pursued for the next phase of development of rectal microbicides. Section III: Objective: The objective of this study was to explore the luminal distribution and clearance of cell-associated (lymphocytes) and cell-free (seminal plasma) HIV surrogates within the distal colon following simulated receptive anal intercourse. Methods: Six healthy, HIV- uninfected men gave semen samples in sterile containers. Samples were centrifuged and the supernatant (seminal plasma) collected and frozen. Peripheral blood lymphocytes were harvested ii from subjects via apheresis and labeled with 111Indium (In)-oxine on the dosing day. 111In-labeled autologous lymphocytes and 99Technetium (Tc)-sulfur colloid (HIV surrogate) were reconstituted with 3 mL of autologous seminal plasma. Reconstituted seminal plasma was inserted into the rectum using a phallic device with artificial urethra. Distribution of radiolabels in time and space was assessed with SPECT/CT at 3 timepoints. Analysis of radiolabel distribution was performed using a flexible principal curve algorithm in R. Pharmacokinetic distance parameters were defined. Results: Median (interquartile range (IQR)) PK distance paarameters for cell-associated (In) and cell-free (Tc) HIV surrogate were described; distribution was similar between cell-free and cell- associated HIV surrogate. Conclusions: Both autologous lymphocytes and HIV surrogate particle in seminal plasma distribute to a maximal distance of around 15 cm from the anorectal junction (which is ~19 cm from the anal verge), with a maximal signal intensity around 6 cm from the anorectal junction. This represents and maps the ideal target distribution for rectal microbicides. Section IV: Objectives: This study aimed to characterize attitudes to long-acting antiretrovirals (LAARV), among youth aged 13 to 24 years living with perinatally- and non-perinatally-acquired HIV (PHIV and NPHIV, respectively). Methods: A cross-sectional survey of 303 Youth Living with HIV (YHIV) followed at four pediatric/adolescent HIV clinics in the USA was performed. Findings: Overall, 88% of YHIV reported probable or definite willingness to use LAARV. The enthusiasm level was similar between PHIV and NPHIV youth (p=0.93). Youth with HIV viral load >1000 copies/mL had significantly higher interest than youth with suppressed viral load (PR 1.12 [95% CI: 1.03 - 1.20]; p= 0.005). Proportion of respondents endorsing definite willingness to use was significantly higher with decreased injection frequency compared to increased injection frequency. Conclusions: YHIV at four urban US pediatric/adolescent HIV clinics had high levels of enthusiasm for LAARV. LAARV should be given high priority as a potentially viable treatment option to improve clinical outcomes in YHIV. iii Dissertation Readers Brian Caffo (committee chair), Craig Hendrix (thesis advisor), Diane Griffin (academic advisor), Khalil Ghanem, David Levine iv Preface “One of the first duties of the physician is to educate the masses not to take medicine.” --W. Osler v Acknowledgments All thanks are due to my mentors Craig Hendrix and Allison Agwu for their patient and wise guidance throughout my time in the GTPCI program, and for helping me to develop the work and ideas contained in this thesis. My gratitude also goes to the GTPCI program leadership and administrators for their calm stewardship over the years. The participants in these challenging studies devoted their time, vital resources and energies to the project of expanding scientific understanding, and have thus earned my profound gratitude. Love and thanks to MDEMQF, T, S, and s, who have given me their unflinching fandom and love, have sat companionably with me through many long nights and Grape-Nuts moments, and some of whom even went so far as to attend my thesis defense in a Derby hat. vi Table of Contents Section I: Introduction………………………………………………………..……………….Page 1 Section II: A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability…………………………………….………...…4 Section III: Colorectal Distribution of Lymphocytes and Cell-Free HIV Surrogate in Autologous Seminal Plasma Following Simulated Anal Intercourse…………………………………….……25 Section IV: Interest of Youth Living with HIV in Long-Acting Antiretrovirals…………….…..44 Section V: Overall Thesis Conclusions………………………………………………………...…73 References: Appendices………………………………………………………………………………………...76 Bibliography……………………………………………………………………………………….94 Curriculum Vitae…………………………………………………………………………………104 vii List of Tables Table IIa. Summary of Adverse Events…………………………………………………….…..…..13 Table IIb. Averaged Perceptibility (User Sensory Perception and Experience (USPE)) Scale Item Scores, Standard Deviations, Cronbach’s Coefficient Alphas (CCA), Cohen’s Effect Sizes (d), and p-values for Low- and High-volume Gel Comparisons……………………………………....……15 Table IIIa. Pharmacokinetic Distance Parameters for Distribution of 111In-Labeled Lymphocytes and 99Tc-labeled HIV Surrogate Particle Through Colorectal Space…………..…….…..……..….35 Table IIIb. P-values (direction of difference) for comparison of PK Distance Parameters by Timepoint………………………………………………………………………………………….36 Table IVa. Baseline Characteristics Stratified by Mode of Acquisition of HIV…………………...52 Table IVb. Crude and adjusted Prevalence Ratio (PR) and 95% Confidence Interval of the interest level in Intramuscular LAARV by Poisson Regression with robust variance…………………..…54 Table IVc. Female participants’ willingness to try IM and implantable LAARV based on past experience with contraceptive technologies…………………..…………………………………..59 viii List of Figures Figure IIa: Study Schema………………………………………………………………………..…..9 Figure IIb. Pharmacokinetic distance parameters for two volumes (3.5 mL and 10 mL) of HEC gel delivered through applicator……………………………………………………………….…....…18 Figure IIIa. Distance Parameters Versus Time for Cell-Associated and Cell-Free HIV Surrogates…………………………………………………………………………………….…….37 Figure IVa. Youth Preference for Intramuscular over Subdermal Implantable LAARV…….……53 Figure IVb. Adjusted Prevalence Ratio of High Interest in LAARV By Participant Characteristics……………………………………………………………………………………...56 Figure IVc. Comparison of Interest in LAARv by Various Characteristics………………..…..….57 Figure IVd.1: Gradient of Definite or Probable Willingness to Use Increases with Decreased Injection Frequency………………………………………………………………….……………..60 Figure IVd.2: Proportion of Definite Willingness to Use Is Higher with Decreased Injection Frequency Compared to Increased Injection Frequency…………………………………………...61 ix Section I: Introduction The broad significance of this research to medicine is that it lays the groundwork for new dosing and delivery approaches for the biomedical prevention and treatment of HIV while directly tackling the problem of poor adherence to biomedical interventions—the Achilles heel of even the most dazzling, painstakingly conceived and researched, and life-saving of technologies. (1) In the words of former U.S. Surgeon General C. Everett Koop, “drugs don’t work in patients who don’t take them.” (2) Non-adherence (not taking medications as prescribed, or not taking prescribed medicines at all) has been called “America’s other drug problem”, and is estimated to be responsible for $300 billion in avoidable health care costs and 125,000 preventable deaths yearly. (3) Non-adherence to HIV biomedical prevention technologies such as pre-exposure prophylaxis (PrEP) leads to HIV acquisition in certain risk settings, and in the realm of HIV treatment, now that treatment as prevention is a better understood prevention strategy, non-adherence leads not only to potentially disastrous consequences
Recommended publications
  • Acceptability of Potential Rectal Microbicide Delivery Systems for HIV Prevention: a Randomized Crossover Trial
    AIDS Behav DOI 10.1007/s10461-012-0358-z ORIGINAL PAPER Acceptability of Potential Rectal Microbicide Delivery Systems for HIV Prevention: A Randomized Crossover Trial Heather A. Pines • Pamina M. Gorbach • Robert E. Weiss • Kristen Hess • Ryan Murphy • Terry Saunders • Joelle Brown • Peter A. Anton • Ross D. Cranston Ó Springer Science+Business Media New York 2012 Abstract We assessed the acceptability of three of over- acceptability and should be considered early in RM devel- the-counter products representative of potential rectal opment to enhance potential use. microbicide (RM) delivery systems. From 2009 to 2010, 117 HIV-uninfected males (79 %) and females (21 %) who Keywords Anorectal products Á Receptive anal engage in receptive anal intercourse participated in a 6-week intercourse Á HIV prevention randomized crossover acceptability trial. Participants received each of three products (enema, lubricant-filled applicator, suppository) every 2 weeks in a randomized Introduction sequence. CASI and T-ACASI scales assessed product acceptability via Likert responses. Factor analysis was used to Rectal microbicides (RM) can be formulated as gels, creams, identify underlying factors measured by each scale. Random or enemas for application inside the rectum to prevent HIV effects models were fit to examine age and gender effects on infection during anal intercourse (AI). Among 24,787 men product acceptability. Three underlying factors were identi- who have sex with men (MSM) who completed an online fied: Satisfaction with Product Use, Sexual Pleasure,and survey in the United States in 2010, 36 and 34 % reported Ease of Product Use. For acceptability, the applicator ranked having receptive anal intercourse (RAI) and insertive anal highest; however, differences between product acceptability intercourse (IAI) at last sex, respectively [1].
    [Show full text]
  • The Mediating Role of Condom Use and Rectal Bleeding in a National Onli
    Epidemiology Sex Transm Infect: first published as 10.1136/sextrans-2019-054415 on 5 May 2020. Downloaded from Original research Association between rectal douching and HIV acquisition: the mediating role of condom use and rectal bleeding in a national online sample of Chinese men who have sex with men Tianyi Lu,1 Xiang Mao,1 Erlei Peng,1 Yangyang Gao,1 Zhenxing Chu,1 Willa Dong,2 Wenran Zhang,1 Yong- Jun Jiang,1 Junjie Xu 1 1NHC Key Laboratory of AIDS ABSTRact challenge imposed by the HIV epidemic among Immunology (China Medical Objectives Previous studies have demonstrated that certain populations, particularly MSM. National University), National Clinical Research Center for Laboratory rectal douching (RD) is associated with HIV acquisition surveillance data have indicated that the preva- Medicine, The First Affiliated among men who have sex with men (MSM). However, lence of HIV among MSM increased from 0.9% in Hospital of China Medical the precise mechanism underlying the association 2003 to 8% in 2015.3 4 Given the disproportion- University, Shenyang, China 2 between RD and HIV remains unclear. ately high burden of HIV infection among MSM, Department of Health Behavior, Methods We recruited participants over WeChat from it is essential to understand the sexual behaviours Gillings School of Global Public Health, The University of North October 2017 to October 2018. Respondents received and preferences of this key population in order to Carolina at Chapel Hill, Chapel mailed HIV self-testing kits, uploaded images of HIV develop a novel and effective strategy to prevent Hill, North Carolina, USA self-test results and completed an online electronic HIV infection.
    [Show full text]
  • Case 1:18-Cv-00641-LMB-IDD Document 26-5 Filed 07/19/18 Page 1 of 113 Pageid# 244
    Case 1:18-cv-00641-LMB-IDD Document 26-5 Filed 07/19/18 Page 1 of 113 PageID# 244 Exhibit E Case 1:18-cv-00641-LMB-IDD Document 26-5 Filed 07/19/18 Page 2 of 113 PageID# 245 UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Alexandria Division NICHOLAS HARRISON and OUTSERVE-SLDN, INC. Plaintiffs, v. Case No. 1:18-cv-641 (LMB/IDD) JAMES N. MATTIS, in his official capacity as Secretary of Defense; MARK ESPER, in his official capacity as the Secretary of the Army; and the UNITED STATES DEPARTMENT OF DEFENSE, Defendants. EXPERT DECLARATION OF CRAIG W. HENDRIX, M.D., IN SUPPORT OF PLAINTIFFS’ MOTION FOR PRELIMINARY INJUNCTION 1 Case 1:18-cv-00641-LMB-IDD Document 26-5 Filed 07/19/18 Page 3 of 113 PageID# 246 I. INTRODUCTION 1. My name is Craig W. Hendrix. I have been retained by counsel for Plaintiffs as an expert in connection with this litigation. 2. I am offering this declaration to provide my expert opinions regarding the U.S. Department of Defense and U.S. Army policies with respect to people living with HIV, including the purported medical justifications for preventing individuals living with HIV from joining the United States military, from being commissioned as officers, and—if already in the military— from deploying outside the United States. 3. As detailed below, it is my opinion that there are no medical justifications for excluding individuals from serving in any capacity in the military or from being deployed outside of the United States based solely on their HIV-positive status.
    [Show full text]
  • Prevalence and Types of Rectal Douches Used for Anal Intercourse Among Men Who Have Sex with Men in Brazil
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2016-011122 on 29 May 2017. Downloaded from Prevalence and types of rectal douches used for anal intercourse among men who have sex with men in Brazil Luiz Carlos Ribeiro Lamblet,1 Roberto José Carvalho da Silva2 To cite: Lamblet LCR, da ABSTRACT Strengths and limitations of this study Silva RJC. Prevalence and Introduction Rectal douching (RD) is practised among types of rectal douches used men who have sex with men (MSM), and various products for anal intercourse among ► Pioneering study in Brazil. and materials are used. There have been no studies in men who have sex with ► Basis for discussion of the issue in the country. Brazil on this practice and its risks in the transmission of men in Brazil. BMJ Open ► Unrepresentative sample of men who have sex with 2017;7:e011122. doi:10.1136/ sexually transmitted infections and HIV. men. bmjopen-2016-011122 Method Between June and August 2015, 401 MSM over the age of 18 were interviewed about their sexual ► Prepublication history and additional material are available. practices associated with RD over the last 3 months. RD group. Studies conducted between 2009 and To view these files please visit was associated with the reported sexual behaviour, and 2013 in Brazil in the MSM population show descriptive statistical analyses were conducted on the the journal online (http:// dx. doi. an HIV prevalence rate of 10.5%.7 8 One of org/ 10. 1136/ bmjopen- 2016- same. the main avenues of the spread of HIV among 011122).
    [Show full text]
  • Effect of Rectal Douching/Enema on Rectal Gonorrhoea and Chlamydia Among a Cohort of Men Who Have Sex with Men on HIV Pre-Exposure Prophylaxis
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Sex Transm Manuscript Author Infect. Author Manuscript Author manuscript; available in PMC 2019 November 01. Published in final edited form as: Sex Transm Infect. 2018 November ; 94(7): 508–514. doi:10.1136/sextrans-2017-053484. Effect of Rectal Douching/Enema on Rectal Gonorrhoea and Chlamydia Among a Cohort of Men Who Have Sex with Men on HIV Pre-Exposure Prophylaxis Adiba Hassan1, Jill S. Blumenthal1, Michael P. Dube2, Eric Ellorin1, Katya Corado3, David J. Moore4, Sheldon R. Morris1, and The California Collaborative Treatment Group (CCTG) 595 Team 1Department of Medicine, University of California San Diego Antiviral Research Center, San Diego, CA, USA 2Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA 3Division of HIV Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA 4Department of Psychiatry, University of California San Diego School of Medicine, San Diego, CA, USA Abstract INTRODUCTION—Rectal douching/enema (RD) is a common practice among men who have sex with men (MSM) in preparation for sex. RD can break down the rectal mucosal barrier and potentially affect the rectal microbiome, however, it is unclear if this is associated with acquiring rectal infections (RI) with either rectal gonorrhoea (NG) and/or chlamydia (CT). METHODS—From 2013–2015, 395 adult HIV-uninfected MSM were enrolled in a randomized controlled study for pre-exposure prophylaxis (PrEP) adherence with routine sexual risk survey and testing. Using data from this cohort, baseline differences by RI were assessed using Pearson’s Chi-square and Wilcoxon-Mann-Whitney test.
    [Show full text]
  • Prevalence and Types of Rectal Douches Used for Anal Intercourse
    Javanbakht et al. BMC Infectious Diseases 2014, 14:95 http://www.biomedcentral.com/1471-2334/14/95 RESEARCH ARTICLE Open Access Prevalence and types of rectal douches used for anal intercourse: results from an international survey Marjan Javanbakht1*, Shauna Stahlman1, Jim Pickett2, Marc-André LeBlanc2 and Pamina M Gorbach1 Abstract Background: Rectal products used with anal intercourse (AI) may facilitate transmission of STIs/HIV. However, there is limited data on rectal douching behavior in populations practicing AI. We examined the content, types of products, rectal douching practices and risk behaviors among those reporting AI. Methods: From August 2011 to May 2012, 1,725 women and men reporting receptive AI in the past 3 months completed an internet-based survey on rectal douching practices. The survey was available in English, French, German, Mandarin, Portuguese, Russian, Spanish, and Thai and included questions on sexual behaviors associated with AI including rectal douching. Differences by rectal douching practices were evaluated using chi-square methods and associations between reported douching practices and other factors including age and reported STI history were evaluated using logistic regression analysis. Results: Respondents represented 112 countries, were mostly male (88%), and from North America (55%) or Europe (22%). Among the 1,339 respondents (66%) who reported rectal douching, most (83%) reported always/almost always douching before receptive AI. The majority of rectal douchers reported using non-commercial/homemade products (93%), with water being the most commonly used product (82%). Commercial products were used by 31%, with the most common product being saline-based (56%). Rectal douching varied by demographic and risk behaviors.
    [Show full text]
  • ( 12 ) United States Patent
    US010092509B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 , 092 ,509 B2 Maisel et al. ( 45 ) Date of Patent: Oct. 9 , 2018 ( 54 ) HYPOTONIC MICROBICIDAL ( 52 ) U .S . CI. FORMULATIONS AND METHODS OF USE CPC .. .. A61K 9 /0031 ( 2013. 01 ); A61K 31/ 52 ( 2013 .01 ) (71 ) Applicant: The Johns Hopkins University, ( 58 ) Field of Classification Search Baltimore, MD (US ) None ( 72 ) Inventors: Katharina Maisel , Troy , MI (US ) ; See application file for complete search history. Craig W . Hendrix , Ellicott City , MD (US ) ; Laura Ensign , Towson , MD ( 56 ) References Cited (US ) ; Edward Fuchs , Westminster , MD ( US ) ; Richard Cone , Baltimore , MD U . S . PATENT DOCUMENTS (US ) ; Justin Hanes, Baltimore , MD 4 , 997 ,652 A 3 / 1991 Wong (US ) 5 ,034 , 506 A 7 / 1991 Summerton ( 73 ) Assignee : The Johns Hopkins University , (Continued ) Baltimore, MD (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer, the term of this WO 9207866 5 / 1992 patent is extended or adjusted under 35 WO 2006063249 6 /2006 U . S . C . 154 (b ) by 0 days . ( Continued ) (21 ) Appl. No .: 15/ 120 , 852 OTHER PUBLICATIONS ( 22 ) PCT Filed : Aug . 27, 2015 Lisco , et al. Cell Host Microbe. , 4 : 260 . ( Year : 2011) . * ( 86 ) PCT No. : PCT /US2015 / 017120 ( Continued ) $ 371 ( c) ( 1 ), Primary Examiner — Michael Barker ( 2 ) Date : Aug. 23, 2016 ( 74 ) Attorney , Agent, or Firm — Pabst Patent Group LLP ( 87) PCT Pub . No. : WO2015 /127368 (57 ) ABSTRACT PCT Pub . Date : Aug . 27, 2015 Hypotonic microbicidal compositions including an antimi crobial , such as an antiviral compound , and a pharmaceuti (65 ) Prior Publication Data cally acceptable carrier in a solution formulation having US 2017/ 0119662 A1 May 4 , 2017 hypotonic osmolarity have been developed for administra tion rectally to the gastrointestinal mucosa .
    [Show full text]
  • The Use of Rectal Douches Among HIV-Uninfected and Infected Men Who Have Unprotected Receptive Anal Intercourse: Implications for Rectal Microbicides
    AIDS Behav DOI 10.1007/s10461-007-9301-0 ORIGINAL PAPER The Use of Rectal Douches among HIV-uninfected and Infected Men who Have Unprotected Receptive Anal Intercourse: Implications for Rectal Microbicides Alex Carballo-Die´guez Æ Jose´ A. Bauermeister Æ Ana Ventuneac Æ Curtis Dolezal Æ Ivan Balan Æ Robert H. Remien Ó Springer Science+Business Media, LLC 2007 Abstract Although some rectal douches result in surface Keywords Receptive anal sex Á Douching Á Homosexual Á epithelium loss and potential increase of HIV transmission, Gay Á Enema men who have sex with men (MSM) continue to use them. We describe the prevalence of this practice among MSM engaging in unprotected receptive anal intercourse (URAI) Introduction in risky circumstances. A multiethnic sample with over- representation of HIV-negative MSM who had URAI in the Since the early days of the AIDS epidemic, scientists have previous year was recruited exclusively through the Inter- found associations between the use of rectal enemas or net. Participants were 105 MSM (78 HIV-negative, 27 douches and HIV as well as other sexually-transmitted HIV-positive). A total of 53% of HIV-negative and 96% of infections (Bienzle et al. 1985; Deininger et al. 1990; HIV-positive men douched in preparation for sex, most of Koziol et al. 1993; Moss et al. 1987; Ndimbie et al. 1996; them frequently or always, mainly for hygienic purposes. Schreeder et al. 1982). Most of the studies were correla- 27% of HIV-negative and 44% of HIV-positive douched tional, speculating that douching had deleterious effects on after sex, partly believing douching protected from infec- the rectum, but evidence was lacking until Schmelzer et al.
    [Show full text]
  • N an O Te Ch N O Lo Gy-B Ase D S Trate Gie S Fo R R E Ctal a N Ti-H IV P Re
    Rute Sofia Nunes Rute Sofia HIV Pre Nanotechnology Anti Rectal Rute Sofia Nunes Rute Sofia Nunes Rute Sofia HIV Pre Nanotechnology Rectal Anti Rute Sofia Nunes Rute Sofia Nunes Rute Sofia Nanotechnology Rute Sofia Nunes Sofia Nunes DOUTORAMENTO CIÊNCIAS BIOMÉDICAS INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR ABEL BIOMÉDICAS CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR ABEL BIOMÉDICAS CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR ABEL BIOMÉDICAS CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABELSALAZAR ABELSALAZAR BIOMÉDICAS BIOMÉDICAS CIÊNCIAS DE CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR BIOMÉDICAS CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR ABEL BIOMÉDICAS CIÊNCIAS DE INSTITUTO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR ABEL BIOMÉDICAS CIÊNCIAS DE INSTITUTO Nanotechnology- Based Strategies for - Exposure Prophylaxis Exposure Prophylaxis Exposure Prophylaxis Exposure Prophylaxis Exposure Exposure Prophylaxis Exposure - HIV Pre HIV HIV Pre HIV Pre HIV Rectal Anti- HIV Pre- Exposure - . Based Strategies for Rectal A Based Strategies Strategies for for Rectal Rectal A A Based Strategies for Rectal A Based Strategies for Rectal A Based Based Strategies for Rectal A - Exposure Prophylaxis ExposureProphylaxis ExposureProphylaxis ExposureProphylaxis Prophylaxis Nanotechnology Nanotechnology Rute Sofia Nunes - - Based Strategies for Based Strategies Strategies for for Based Strategies for nti nti - D .ICBAS .ICBAS 2018 2018 Rute Sofia Gonçalves
    [Show full text]
  • HIV Cover Ok
    HIV Counselling Handbook for the Asia-Pacific A comprehensive guide to: ● Voluntary counselling and testing ● Provider-initiated testing and counselling ● Treatment and care counselling South-East Asia Region Western Pacific Region HIV Counselling Handbook for the Asia-Pacific A comprehensive guide to: ● Voluntary counselling and testing ● Provider-initiated testing and counselling ● Treatment and care counselling South-East Asia Region Western Pacific Region Copyright © UNICEF East Asia and Pacific Regional Office, 2009 Any part of this document may be freely reproduced with the appropriate acknowledgement. UNICEF East Asia and Pacific Regional Office Tel: (66 2) 356 9499 Fax: (66 2) 280 7056 E-mail: [email protected] Website: www.unicef.org/eapro Design and Layout by: Keen Media (Thailand) Co., Ltd. Printed in Thailand Cover photos: The Maternal and Child Health staff, mother and child: G.Pirozzi /UNICEF PNG/2006 Teacher and children: unknown/UNICEF PNG/2004 Group counselling: Family Health International – Bangladesh Female counselling a female: Family Health International – Asia and Pacific Regional Office Male counselling a male: Family Health International – Indonesia Transgender being counselled: Family Health International – Indonesia ISBN: 978-974-685-112-1 Acknowledgements This handbook was developed for trainers, counsellors in training, and working counsellors to assist them in delivering high-quality HIV testing and counselling services. It highlights the important contribution of counsellors to HIV prevention, care, and support activities and forms one of three parts of the HIV Counselling Resource Package, which also includes trainer’s session plans, participatory learning activities, and an HIV counsellor’s toolkit. This handbook could not have been developed without the help of many people working in HIV counselling, care support, and treatment throughout the Asia and Pacific regions.
    [Show full text]
  • Rectal Douching and Implications for Rectal Microbicides Among Populations Vulnerable to Hiv in South America: a Qualitative Study Jerome T
    University of South Florida Scholar Commons Social Work Faculty Publications Social Work 2014 Rectal Douching and Implications for Rectal Microbicides Among Populations Vulnerable to Hiv in South America: a Qualitative Study Jerome T. Galea University College London, [email protected] Janni J. Kinsler University of California John Imrie University College London César R. Nureña Universidad Nacional Mayor de San Marcos Jorge Sánchez Asociación Civil Impacta Salud y Educación See next page for additional authors Follow this and additional works at: https://scholarcommons.usf.edu/sok_facpub Part of the Social Work Commons Scholar Commons Citation Galea, Jerome T.; Kinsler, Janni J.; Imrie, John; Nureña, César R.; Sánchez, Jorge; and Cunningham, William E., "Rectal Douching and Implications for Rectal Microbicides Among Populations Vulnerable to Hiv in South America: a Qualitative Study" (2014). Social Work Faculty Publications. 43. https://scholarcommons.usf.edu/sok_facpub/43 This Article is brought to you for free and open access by the Social Work at Scholar Commons. It has been accepted for inclusion in Social Work Faculty Publications by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Authors Jerome T. Galea, Janni J. Kinsler, John Imrie, César R. Nureña, Jorge Sánchez, and William E. Cunningham This article is available at Scholar Commons: https://scholarcommons.usf.edu/sok_facpub/43 NIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2014 August 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Sex Transm Infect. 2014 February ; 90(1): 33–35. doi:10.1136/sextrans-2013-051154.
    [Show full text]
  • Rectal Douching Injury in Men Who Have Sex with Men
    Rectal Douching Injury in Men Who Have Sex With Men Heather Boerner November 21, 2019 https://www.medscape.com/viewarticle/921697?src=WNL_infoc_191212_MSCPEDIT_TEMP2&uac=17075SY&impID=2199837&faf=1#vp_1 PORTLAND, Oregon — Jamey Scott, RN, was meeting with a patient at the Ryan White clinic where she works in Richmond, Virginia, when he mentioned that he "douched" in preparation for sex. The word stopped her, but Scott kept moving. Her training in HIV taught her that "you can't bat an eye" when patients say things that surprise you. But she did need to know more. "I asked, 'Are you using like a Summer's Eve–type product or are you using a Fleet [enema]?" she said. "I just put it out there. If they're going to be bold enough to tell me, I'm going to be bold enough to ask." According to data presented at the Association of Nurses in AIDS Care 2019 Conference, half the gay and bisexual black men in the Deep South have used an enema — or "rectal douche" as it's called in the community — although what they are using to douche is unclear. For men who are receptive partners, it's even more common. This is despite the conventional wisdom that no one should regularly use an enema unless they have a neurologic condition, such as multiple sclerosis or spinal cord injuries, that necessitates it. Data also show that enemas, along with other sexual-hygiene practices, could increase the risk for HIV transmission and other sexually transmitted infections (STIs). But there are formulations that are safer, and research is ongoing into medicated formulations.
    [Show full text]